102 related articles for article (PubMed ID: 9568075)
1. The p53 gene in soft tissue sarcomas: prognostic value of DNA sequencing versus immunohistochemistry.
Taubert H; Würl P; Bache M; Meye A; Berger D; Holzhausen HJ; Hinze R; Schmidt H; Rath FW
Anticancer Res; 1998; 18(1A):183-7. PubMed ID: 9568075
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of p53 exon 4 mutations in soft tissue sarcoma.
Das P; Kotilingam D; Korchin B; Liu J; Yu D; Lazar AJ; Pollock RE; Lev D
Cancer; 2007 Jun; 109(11):2323-33. PubMed ID: 17429838
[TBL] [Abstract][Full Text] [Related]
3. [p53 overexpression as independent prognostic marker in soft tissue sarcomas is antibody dependent].
Würl P; Taubert H; Meye A; Berger D; Holzhausen HJ; Schmidt H; Hinze R; Rath FW; Schönfelder M
Verh Dtsch Ges Pathol; 1998; 82():358-61. PubMed ID: 10095460
[TBL] [Abstract][Full Text] [Related]
4. [Frequency, distribution and prognostic relevance of p53 mutations in soft tissue sarcomas].
Taubert H; Würl P; Meye A; Bache M; Kroll J; Lautenschläger C; Thamm B; Holzhausen HJ; Hinze R; Schmidt H; Berger D; Rath FW
Verh Dtsch Ges Pathol; 1998; 82():340-4. PubMed ID: 10095457
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of p53 protein overexpression versus gene sequencing in urinary bladder carcinomas.
Bernardini S; Adessi GL; Billerey C; Chezy E; Carbillet JP; Bittard H
J Urol; 1999 Oct; 162(4):1496-501. PubMed ID: 10492244
[TBL] [Abstract][Full Text] [Related]
6. Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas.
Liu FS; Kohler MF; Marks JR; Bast RC; Boyd J; Berchuck A
Obstet Gynecol; 1994 Jan; 83(1):118-24. PubMed ID: 8272291
[TBL] [Abstract][Full Text] [Related]
7. p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status.
Tolbert DM; Noffsinger AE; Miller MA; DeVoe GW; Stemmermann GN; Macdonald JS; Fenoglio-Preiser CM
Mod Pathol; 1999 Jan; 12(1):54-60. PubMed ID: 9950163
[TBL] [Abstract][Full Text] [Related]
8. No p16INK4A/CDKN2/MTS1 mutations independent of p53 status in soft tissue sarcomas.
Meye A; Würl P; Hinze R; Berger D; Bache M; Schmidt H; Rath FW; Taubert H
J Pathol; 1998 Jan; 184(1):14-7. PubMed ID: 9582521
[TBL] [Abstract][Full Text] [Related]
9. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas.
Mousses S; McAuley L; Bell RS; Kandel R; Andrulis IL
Mod Pathol; 1996 Jan; 9(1):1-6. PubMed ID: 8821948
[TBL] [Abstract][Full Text] [Related]
10. Implications of p53 gene mutations on patient survival in transitional cell carcinoma of the bladder: a long-term study.
Salinas-Sánchez AS; Lorenzo-Romero JG; Giménez-Bachs JM; Sánchez-Sánchez F; Donate-Moreno MJ; Rubio-Del-Campo A; Hernández-Millán IR; Segura-Martín M; Atienzar-Tobarra M; Escribano-Martínez J
Urol Oncol; 2008; 26(6):620-6. PubMed ID: 18367096
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity and specificity of p53 protein detection by immunohistochemistry in patients with urothelial bladder carcinoma.
Salinas-Sánchez AS; Atienzar-Tobarra M; Lorenzo-Romero JG; Sánchez-Sánchez F; Giménez-Bachs JM; Donate-Moreno MJ; Pastor-Navarro H; Hernández-Millán I; Segura-Martín M; Escribano-Martínez J
Urol Int; 2007; 79(4):321-7. PubMed ID: 18025850
[TBL] [Abstract][Full Text] [Related]
12. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.
Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH
Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773
[TBL] [Abstract][Full Text] [Related]
13. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer.
Chang MY; Chong IW; Chen FM; Wang JY; Cheng TL; Cheng YJ; Sheu CC; Hung SY; Yang MC; Lin SR
Cancer Lett; 2005 May; 222(2):195-204. PubMed ID: 15863268
[TBL] [Abstract][Full Text] [Related]
14. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
[TBL] [Abstract][Full Text] [Related]
15. Prognosis is correlated with p53 mutation type for soft tissue sarcoma patients.
Taubert H; Meye A; Würl P
Cancer Res; 1996 Sep; 56(18):4134-6. PubMed ID: 8797580
[TBL] [Abstract][Full Text] [Related]
16. p53 mutation and detection of p53 protein expression in oral leukoplakia and oral squamous cell carcinoma.
Ries JC; Schreiner D; Steininger H; Girod SC
Anticancer Res; 1998; 18(3B):2031-6. PubMed ID: 9677462
[TBL] [Abstract][Full Text] [Related]
17. Patterns of p53 gene mutations in head and neck cancer: full-length gene sequencing and results of primary radiotherapy.
Saunders ME; MacKenzie R; Shipman R; Fransen E; Gilbert R; Jordan RC
Clin Cancer Res; 1999 Sep; 5(9):2455-63. PubMed ID: 10499619
[TBL] [Abstract][Full Text] [Related]
18. p53 gene mutations and p53 protein expression in human soft tissue sarcomas.
Yoo J; Lee HK; Kang CS; Park WS; Lee JY; Shim SI
Arch Pathol Lab Med; 1997 Apr; 121(4):395-9. PubMed ID: 9140310
[TBL] [Abstract][Full Text] [Related]
19. Distribution of p53 mutations in esophageal and gastric carcinomas and the relationship with p53 expression.
Hanazono K; Natsugoe S; Stein HJ; Aikou T; Hoefler H; Siewert JR
Oncol Rep; 2006 Apr; 15(4):821-4. PubMed ID: 16525665
[TBL] [Abstract][Full Text] [Related]
20. Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer.
Kaserer K; Schmaus J; Bethge U; Migschitz B; Fasching S; Walch A; Herbst F; Teleky B; Wrba F
J Pathol; 2000 Mar; 190(4):450-6. PubMed ID: 10699994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
